Aug 2026· Computational and Structural Biotechnology Journal· Vol 35· 0 citations· 29 references
Medicine
TL;DR
This framework establishes a scalable, human-relevant, and genetically diverse platform for cardiotoxicity surveillance across both pharmacological and environmental chemical spaces and identified microbiocides, dyes, and pesticides as chemical classes of potential concern.
Abstract
Cardiotoxicity remains a major cause of drug attrition and postmarket withdrawal, yet the vast majority of environmental chemicals to which humans may be exposed remain uncharacterized for cardiotoxicity risk. Human induced pluripotent stem cell (hiPSC)-based testing has been proposed to address this gap. Here, we present an unsupervised deep learning framework for multi-donor cardiotoxicity screening using high-throughput calcium transient recordings from hiPSC-derived cardiomyocytes (hiPSC-CMs). We analyzed data from a library of 1,029 compounds tested in hiPSC-CMs from 5 donors across a concentration range. An autoencoder trained exclusively on baseline signals quantified chemically induced functional perturbations through reconstruction error, bypassing the need for labeled training data while capturing the full spectrum of calcium-handling disruptions. Aggregation of donor-specific scores revealed substantial inter-individual variability in potential cardiotoxicity, underscoring the value of this approach for multi-donor risk prediction. We identified microbiocides, dyes, and pesticides as chemical classes of potential concern, characterized by high toxicity scores and low interdonor variability. This framework establishes a scalable, human-relevant, and genetically diverse platform for cardiotoxicity surveillance across both pharmacological and environmental chemical spaces.
Evaluating chemical hazards, such as cardiotoxicity, is critical for sound chemical management but is challenging due to the labor-intensive and time-consuming nature of in vivo testing. In silico models can efficiently and cost-effectively screen potential cardiotoxic compounds from a large number of chemicals. Howe...
Yuxuan Zhang, Yuwei Liu, Guijia Bi et al.· Chemical Research in Toxicol...· 0 citations
Motivation for this research stems from drug-induced liver injury (DILI) being a leading cause of drug failure and market withdrawal, which calls for reliable, non-invasive hepatotoxicity assessment. The basis for this research was the work performed by Dubinsky et al., who established a deep learning (DL) model to pre...
M. Jordovic-Pavlovic, Tijana Geroski, Milica Nikolić· Conference proceedings· 0 citations
This review discusses recent progress in ML, DL, and AI-based strategies for toxicity prediction, assesses their utility across major toxicity endpoints, and highlights the challenges and future research opportunities in predictive toxicology.
Anjali Mahavar, Atul Patel, Ashish Patel· Current Chemical Biology· 0 citations
A framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets to retain the baseline’s generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data is proposed.
C. Barajas, Laura L. Dunphy, Luke C. Mullany et al.· bioRxiv· 0 citations
Despite training on 5000 SMILES due to limited computational resources, the model achieved high validity, strong molecular diversity, and drug-like physicochemical properties, demonstrating the feasibility of a scalable, target-specific AI pipeline for lung cancer drug discovery using fragment-based molecular generatio...
Mohavia Ben Amid Sinon, U. Chude-Okonkwo· Drugs and Drug Candidates· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.